Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

Amendment to the KP415 License Agreement Conference Call

Apr 8, 2021 at 4:30 PM EDT